Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction

Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction

Background and aim:Heart failure with preserved ejection fraction (HFpEF) is associated with an increased risk of heart failure (HF) hospitalizations and cardiovascular death (CVD). Both dapagliflozin and sacubitril-valsartan have recently shown convincing reductions in the combined risk of CVD and...

Full description

Saved in:
Bibliographic Details
Main Authors: Ronen Arbel (Author), Abed N. Azab (Author), Mansi Oberoi (Author), Enis Aboalhasan (Author), Artyom Star (Author), Khaled Elhaj (Author), Fouad Khalil (Author), Hilmi Alnsasra (Author)
Format: Book
Published: Frontiers Media S.A., 2024-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items